Related Experiment Videos
Nonviral ocular gene transfer.
1The Department of Ophthalmology and Neuroscience, Baltimore, MD 21287-9277, USA.
Gene Therapy
|March 25, 2005
Summary
Nonviral gene transfer in the eye using electroporation or lipofection shows promise for retinal gene therapy. These methods enable efficient gene delivery and promoter evaluation, with optimized techniques minimizing retinal damage.
Area of Science:
- Ophthalmology
- Molecular Biology
- Biotechnology
Background:
- Nonviral gene transfer methods are being explored for ocular applications.
- Efficient and safe gene delivery to the eye remains a challenge.
Purpose of the Study:
- To investigate electroporation and lipofection for nonviral gene transfer in the eye.
- To assess the efficacy and safety of these methods for delivering genetic material to retinal cells.
- To evaluate their potential for testing tissue-specific promoters in vivo.
Main Methods:
- Subretinal, intravitreous, and periocular injections of plasmid DNA.
- Combination of plasmid injection with electroporation at varying voltages.
- Plasmid DNA delivery using media promoting lipoplex formation (Lipofectamine2000, NeuroPorter).
- Assessment of gene expression (LacZ staining) and retinal damage (histology, ERGs).
Main Results:
- Electroporation significantly enhanced gene transfer efficiency at all injection sites.
- Optimized electroporation (3.4 V/mm) achieved substantial transduction without photoreceptor damage.
- Lipofection with 10% NeuroPorter enabled RPE cell transduction without adverse effects.
- Gene expression was detectable for at least 14 days and could be reinduced.
Conclusions:
- Electroporation and lipofection are viable experimental tools for ocular gene transfer.
- These methods facilitate the evaluation of tissue-specific promoters and transgene effects in the retina.
- Optimized nonviral gene transfer holds potential for treating retinal and choroidal diseases.